Fundraising September 15, 2024 – October 1, 2024 About fundraising

Entrectinib in patients with ROS1 fusion-positive non-small...

Annals of Oncology 2020 / 09 Vol. 31

Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy

Liu, S.V., De Braud, F., Drilon, A., Doebele, R.C., Patel, M.R., Cho, B.C., Ahn, M-J., Chiu, C-H., Farago, A.F., Goto, K., Lee, J., Ohe, Y., Ou, S-H.I., Cassier, P., Tan, D.S.W., Otterson, G.A., Veron
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.654
Date:
September, 2020
File:
PDF, 114 KB
2020
Conversion to is in progress
Conversion to is failed